| lipid metabolic process |
GO:0006629 |
TAS |
| triglyceride metabolic process |
GO:0006641 |
IEA |
| cholesterol metabolic process |
GO:0008203 |
IEA |
| positive regulation of cholesterol esterification |
GO:0010873 |
TAS |
| negative regulation of phosphatidylcholine catabolic process |
GO:0010900 |
IDA |
| negative regulation of very-low-density lipoprotein particle clearance |
GO:0010916 |
IDA |
| regulation of cholesterol transport |
GO:0032374 |
IC |
| negative regulation of cholesterol transport |
GO:0032375 |
IDA |
| cholesterol efflux |
GO:0033344 |
IDA |
| phospholipid efflux |
GO:0033700 |
IDA |
| plasma lipoprotein particle remodeling |
GO:0034369 |
IDA |
| high-density lipoprotein particle remodeling |
GO:0034375 |
TAS |
| very-low-density lipoprotein particle assembly |
GO:0034379 |
TAS |
| chylomicron remnant clearance |
GO:0034382 |
IDA |
| very-low-density lipoprotein particle clearance |
GO:0034447 |
IGI |
| lipoprotein metabolic process |
GO:0042157 |
IEA |
| positive regulation of catalytic activity |
GO:0043085 |
TAS |
| negative regulation of fatty acid biosynthetic process |
GO:0045717 |
IDA |
| negative regulation of lipid metabolic process |
GO:0045833 |
IDA |
| negative regulation of receptor-mediated endocytosis |
GO:0048261 |
IDA |
| negative regulation of lipid catabolic process |
GO:0050995 |
IDA |
| negative regulation of lipoprotein lipase activity |
GO:0051005 |
IDA |
Human cDNA
